ShareCompartir
QuickStats: Percentage of Adults Aged ≥40 Years Who Ever Had a Cardiovascular Event* and Are Now Taking Low-Dose Aspirin to Prevent or Control Heart Disease, by Sex and Race/Ethnicity — National Health Interview Survey, 2012†
* Includes heart attack (myocardial infarction), angina pectoris, coronary heart disease, or stroke.
† Estimates are based on household interviews of a sample of the noninstitutionalized U.S. civilian population and are derived from the National Health Interview Survey sample adult component.
§ 95% confidence interval.
In 2012, 69.6% of adults aged ≥40 years who ever had a cardiovascular event (73.2% of men and 65.4% of women) were taking low-dose aspirin to prevent or control heart disease. Non-Hispanic white men (75.9%) were more likely to be taking low-dose aspirin compared with Hispanic (60.7%) and non-Hispanic black men (60.6%). No statistically significant differences were oberved among women by race/ethnicity.
Source: National Health Interview Survey, 2012 data. Available at http://www.cdc.gov/nchs/nhis.htm.
Reported by: Renee M. Gindi, PhD, iuz2@cdc.gov, 301-458-4502; Brian W. Ward, PhD.
Alternate Text: The figure above is a bar chart showing the percentage of adults aged ≥40 years who ever had a cardiovascular event and are now taking low-dose aspirin to prevent or control heart disease, by sex and race/ethnicity in the United States during 2012. In 2012, 69.6% of adults aged ≥40 years who ever had a cardiovascular event (73.2% of men and 65.4% of women) were currently taking low-dose aspirin to prevent or control heart disease. Non-Hispanic white men (75.9%) were more likely to be taking low-dose aspirin compared with Hispanic (60.7%) and non-Hispanic black men (60.6%). No statistically significant differences were observed among women by race/ethnicity.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
